Table 5.
Blood cell analysis of COVID-19.
| Moderate | Severe | Critically severe | P-valuea | P-valueb | P-valuec | |
|---|---|---|---|---|---|---|
| YOUNG AGE: 18–44 | ||||||
| Patient no. (43) | 30 | 10 | 3 | |||
| WBC, x109/L | 6.19 (2.2) | 6.49 (2.79) | 6.05 (2.67) | 0.4 | 0.91 | 0.57 |
| Lymphocyte, x109/L | 1.55 (0.5) | 1.05 (0.8) | 0.79 (0.44) | 0.22 | 0.03 | 0.18 |
| Lymphocyte ratio, % | 26.42 (7.8) | 16.98 (8.69) | 16.5 (14.82) | 0.03 | 0.06 | 0.63 |
| Neutrophil, x109/L | 4.11 (1.76) | 5.02 (2.69) | 4.79 (2.62) | 0.16 | 0.53 | 0.84 |
| Platelet, x109/L | 238 (74) | 194 (84) | 120 (36) | <0.05 | 0.01 | 0.22 |
| CRP, mg/L | 12 (22.8) | 67.77 (56.75) | 64.84 (71.12) | 0.27 | 0.1 | 0.08 |
| NLR, % | 2.81 (1.33) | 9.08 (28.29) | 9.51 (9.8) | 0.04 | <0.01 | 0.03 |
| PLR, % | 165 (58) | 234 (170) | 182 (82) | 0.89 | 0.74 | 0.82 |
| MIDDLE AGE: 45–59 | ||||||
| Patient no. (88) | 44 | 33 | 11 | |||
| WBC, x109/L | 5.38 (2.3) | 7.19 (3.17) | 8.27 (4.96) | 0.01 | <0.01 | 0.31 |
| Lymphocyte, x109/L | 1.31 (0.55) | 0.99 (0.37) | 0.67 (0.54) | <0.01 | <0.01 | 0.07 |
| Lymphocyte ratio, % | 26.16 (11.62) | 15.05 (7.64) | 10.44 (10.24) | <0.01 | <0.01 | 0.19 |
| Neutrophil, x109/L | 3.6 (2.2) | 5.64 (3.09) | 7.37 (4.63) | <0.01 | <0.01 | 0.09 |
| Platelet, x109/L | 225 (86) | 214 (103) | 143 (53) | 0.6 | <0.01 | 0.03 |
| CRP, mg/L | 19.22 (40.53) | 67.58 (82.27) | 105 (96) | 0.01 | <0.01 | 0.14 |
| NLR, % | 3.34 (2.82) | 6.97 (6.1) | 14.98 (8.74) | <0.01 | <0.01 | <0.01 |
| PLR, % | 198 (110) | 245 (139) | 300 (185) | 0.13 | 0.02 | 0.23 |
| OLD AGE: ≥60 | ||||||
| Patient no. (173) | 66 | 80 | 27 | |||
| WBC, x109/L | 5.74 (1.74) | 6.32 (2.75) | 9.57 (5.02) | 0.4 | <0.01 | <0.01 |
| Lymphocyte, x109/L | 1.47 (0.67) | 1.09 (1.24) | 0.67 (0.41) | <0.01 | <0.01 | 0.03 |
| Lymphocyte ratio, % | 11.24 (14.44) | 16.73 (8.28) | 9,93 (11.81) | <0.01 | <0.01 | <0.01 |
| Neutrophil, x109/L | 3.72 (1.58) | 4.97 (2.65) | 8.4 (5.05) | 0.03 | <0.01 | <0.01 |
| Platelet, x109/L | 215 (71) | 190 (81) | 191 (102) | 0.03 | 0.19 | 0.81 |
| CRP, mg/L | 16.3 (26.07) | 44.69 (42.17) | 125 (87) | <0.01 | <0.01 | <0.01 |
| NLR, % | 3.25 (2.6) | 20.81 (34.75) | 22.41 (29.1) | 0.1 | <0.01 | 0.04 |
| PLR, % | 178 (101) | 245 (187) | 383 (267) | 0.04 | <0.01 | <0.01 |
P-valuea indicates differences between moderate and severe group; P-valueb indicates differences between moderate and critically severe group; P-valuec indicates differences between severe and critically severe group; P < 0.05 was considered statistically significant.